Discover how The US Oncology Network leverages AI to reduce provider burden, extract clinical data and improve patient outcomes.
Advancing Community Oncology Care
Learn how McKesson is supporting providers and biopharma companies as they find the right treatment options for patients living with cancer.
Today, one in two men and one in three women will hear the words, “You have cancer” in their lifetime. It’s why our company is dedicated to advancing the next generation of cancer care. Through our unparalleled oncology platform, we’re helping bring promising new therapies to market, tackling inequities in healthcare by improving access to care, and providing cutting-edge treatments closer to home.
Learn more about how we’re transforming the fight against cancer in the video above.
Related Stories
At Biologics by McKesson, proactive pharmacy care and personalized support help patients stay on therapies, reduce costs and improve outcomes.
Sarah Cannon Research Institute (SCRI) offers clinical trials in communities close to home, where 85% of patients seek care.
How Shenandoah Oncology became a blueprint for compassion and turned patient feedback into a lifeline.
How community oncology clinics are helping break down barriers to care.
How Biopharma and community oncology are working together to solve healthcare’s toughest challenges and build a more resilient future for cancer care.
Meeting the demands of ultra-sensitive treatments with purpose-built storage, automation and pharmacy integration
In the third episode of our Always Advancing video series, learn how precision and personalized medicine are transforming cancer care – expanding access to clinical trials and novel treatments in communities.
Using McKesson Compile’s analytics to transform how patients with rare blood disorders access specialized care across Indiana.
InspiroGene by McKesson helps patients with rare and severe diseases access innovative cell and gene therapies through personalized support at every step of their journey.